Delayed Release glucocorticoid Treatment of rheumatoid arthritis, Improving signs and symptoms, shows total or complete Clinical response and prevents damage to the joints

摘要

This is about a patient with rheumatoid arthritis whose treatment shows symptoms and symptoms decrease A complete or complete clinical response, or even structural prevention, through delayed release of a form of glucose poisoning to those in need. Item 6: method according to Item 1, 2, 3 or 4,It is characterized by a dose of prednisone equivalent to or less than 10 mg / day or another glucococcus equivalent to start and maintain treatment. Item 13: the method determined according to Item 1, 2, 3 or 4, which is characterized by the fact that the patient has not received the treatment of immediate release of glucose from the mouth before, a USAID, a DMARD, a tnfal inhibitor, an IL-1 inhibitor, a ll-6 inhibitor, a painkiller, or a combination of the two. Requirement No. 14: method taken in accordance with requirement No. 1, 2, 3 or 4,The patient was previously treated with NSAID, DMARD, tnfalf inhibitor, LL-1 inhibitor, IL-6 inhibitor, painkiller or a combination of them. Item 19: the method is consistent with the requirements of item 1, 2, 3 or 4, which is characterized by that this delayed release dose form is more effective in the same dose of glucose poisoning, compared with the use of this glucose poisoning in a direct iiberacion dose form. Item 27: method according to Item 1. 2, 3, 4.The shape labeled as delayed release dose is one tablet or one capsule.